In this section

aBravo is a novel Aedes aegypti antiviral protein that interacts with, but acts independently of, the exogenous siRNA pathway effector Dicer 2

Varjak, M. , Rommel, G., Schnettler, E. and Kohl, A. (2020) aBravo is a novel Aedes aegypti antiviral protein that interacts with, but acts independently of, the exogenous siRNA pathway effector Dicer 2. [Data Collection]

Datacite DOI: 10.5525/gla.researchdata.1010

Related Enlighten Publications

Collection description

These datasets contain luciferase data contained in the paper.

Funding:
College / School: College of Medical Veterinary and Life Sciences > School of Infection and Immunity
Date Deposited: 09 Jul 2020 08:41
URI: https://researchdata.gla.ac.uk/id/eprint/1010

Available Files

Data

Data%20for%20Figures.xlsx
- Data%20for%20Figures.xlsx
Visible to:Anyone
File size:50kB
License:CC BY 4.0

Read me

Readme_1010.docx
- Readme_1010.docx
Visible to:Anyone
File size:12kB
License:CC BY 4.0

Repository Staff Only: Update this record

Cite this record

Varjak, M. , Rommel, G., Schnettler, E. and Kohl, A. (2020); aBravo is a novel Aedes aegypti antiviral protein that interacts with, but acts independently of, the exogenous siRNA pathway effector Dicer 2

University of Glasgow

DOI: 10.5525/gla.researchdata.1010

Retrieved: 2025-11-07

Altmetric
Download Statistics

Downloads

Downloads per month over past year